Related Experiment Video
Updated: Aug 14, 2026

Assessment of Social Interaction Behaviors
Published on: February 25, 2011
Decreased in vivo binding to brain benzodiazepine receptors during social isolation
1Laboratory of Clinical Science, NIMH/NIHAC, Poolesville, MD 20837.
Abstract:
Pharmacologic studies have demonstrated that benzodiazepines can modulate the ultrasonic vocalizations (USV) associated with social separation of rat pups. In this study, in vivo receptor autoradiography was used to determine if brain benzodiazepine receptors were functionally less available to bind an exogenous ligand during social separation. The labelled benzodiazepine receptor antagonist 3H-RO 15-1788 was given to 10-day-old rat pups during 25 minutes of social separation. In autoradiographic studies of brains from separated pups, the binding of 3H-RO 15-1788 was decreased in neocortex (frontal, motor, and somatosensory), hippocampus, and superior and inferior colliculi. As these same regions showed no alteration of in vitro binding of 3H-RO 15-1788, these in vivo binding decreases do not reflect changes in receptor number. The interpretation of decreased in vivo binding and implications of these results for defining the neural substrates of separation behavior are discussed.
Related Concept Videos
CNS Depressants: Alcohol and Nicotine
CNS Depressants: Barbiturates and Benzodiazepines
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Anxiolytic Drugs: Benzodiazepines and Buspirone
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

